Brief exposure of skin to near‐infrared laser augments early vaccine responses
Shinya Yokomizo, Wataru Katagiri, Yohei Maki, Tomoya Sano, Kazumasa Inoue, Masahiro Fukushi, Dmitriy N. Atochin, Toshihiro Kushibiki, Akihiko Kawana, Yoshifumi Kimizuka, Satoshi Kashiwagi
Abstract
Abstract Rapid establishment of herd immunity with vaccination is effective to combat emerging infectious diseases. Although the incorporation of adjuvant and intradermal (ID) injection could augment early responses to the vaccine, the current chemical or biological adjuvants are inappropriate for this purpose with their side effects and high reactogenicity in the skin. Recently, a near‐infrared (NIR) laser has been shown to augment the immune response to ID vaccination and could be alternatively used for mass vaccination programs. Here, we determined the effect of NIR laser as well as licensed chemical adjuvants on the immunogenicity 1, 2, and 4 weeks after ID influenza vaccination in mice. The NIR laser adjuvant augmented early antibody responses, while the widely used alum adjuvant induced significantly delayed responses. In addition, the oil‐in‐water and alum adjuvants, but not the NIR laser, elicited escalated T H 2 responses with allergenic immunoglobulin E (IgE) responses. The effect of the NIR laser was significantly suppressed in the basic leucine zipper transcription factor ATF‐like 3 (Batf3) knockout mice, suggesting a critical role of the cluster of differentiation 103 + (CD103) + dendritic cells. The current preliminary study suggests that NIR laser adjuvant is an alternative strategy to chemical and biological agents to timely combat emerging infectious diseases. Moreover, its immunomodulatory property could be used to enhance the efficacy of immunotherapy for allergy and cancer.